FDA Clears InTouch’s Remote Presence Telemedicine Devices For Active Patient Monitoring

California’s InTouch Health has announced that it has received FDA 510(k) clearance with expanded indications for use for its Remote Presence devices. The range is now approved for active patient monitoring rather than a medical device data system, thereby exemplifying the FDA’s new approach to telemedicine device classification.

Boston Scientific Claims Its U.S. Defibrillators Enjoy Increased Longevity. FDA Agrees

The U.S. FDA has approved revised product labeling for the Boston Scientific Corporation INCEPTA™, ENERGEN™, PUNCTUA™, COGNIS® and TELIGEN® implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), to reflect increased longevity projections for these devices.

FDA 510(k) Clearance for ViewRay’s MRI-Guided Radiation Therapy System

Cleveland medical device company ViewRay Inc., has received U.S. FDA 510(k) premarket notification clearance for its MRI-guided radiation therapy system. The ViewRay system features what the company calls a unique combination of radiotherapy delivery and simultaneous magnetic resonance imaging (MRI) for the treatment of cancer.

FDA Clears Boston Scientific To Expand Indications For CRE™ Balloon To Include Into Stone Extraction

Boston Scientific Corporation has announced the FDA clearance for an expanded use indication for the CRE™ Wireguided Balloon Dilator for endoscopic dilation of the Sphincter of Oddi following sphincterotomy, quite literally opening up the possibility of using it for dilation assisted stone removal.

Most read

Latest

^